Crossref
BRAF/TERT Co-Mutations in Radioiodine-Refractory Differentiated Thyroid Cancer: Association with Aggressive Clinicopathological Features
European Journal of Cancer · 2026-11 · 248 · 117542
DOI: 10.1016/j.ejca.2026.117542 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Cancer, 2026-11. Verfasst von A. Rakhmankulova und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Rakhmankulova, A., & Pak, L. (2026). BRAF/TERT Co-Mutations in Radioiodine-Refractory Differentiated Thyroid Cancer: Association with Aggressive Clinicopathological Features. European Journal of Cancer, 248, 117542. https://doi.org/10.1016/j.ejca.2026.117542
Vancouver
Rakhmankulova A, Pak L. BRAF/TERT Co-Mutations in Radioiodine-Refractory Differentiated Thyroid Cancer: Association with Aggressive Clinicopathological Features. European Journal of Cancer. 2026;248:117542. doi:10.1016/j.ejca.2026.117542
BibTeX
@article{Rakhmankulova2026,
author = {Rakhmankulova, A. and Pak, L.},
title = {BRAF/TERT Co-Mutations in Radioiodine-Refractory Differentiated Thyroid Cancer: Association with Aggressive Clinicopathological Features},
journal = {European Journal of Cancer},
year = {2026},
volume = {248},
pages = {117542},
doi = {10.1016/j.ejca.2026.117542}
}
EUVIMED